Enrofloxacin/hcl

Products Description:

 Function and Application

    This product is a broad-spectrum bactericidal agent, which has special effects on mycoplasma. Coli, Klebsiella, Salmonella, proteus, Pseudomonas aeruginosa, Haemophilus, Pasteurella multocida, hemolytic Pasteurella, Staphylococcus aureus, Streptococcus and all have bactericidal effect.

    Enrofloxacin can be used as animal drug enrofloxacin, in vivo animal has long half-life, good distribution organization, belongs to the broad-spectrum antibacterial agents, antibacterial activity for gram positive bacteria and gram negative bacteria and mycoplasma, was used to control the fish Vibrio disease and disease of Escherichia coli.

    Enrofloxacin is the third generation of quinolone antibacterial drugs, also known as ethyl ciprofloxacin, in October 4, 1996 was approved by FDA, for livestock and aquatic products dedicated quinolones antibacterial drugs. It can bind with the bacterial DNA subunit A, thus inhibiting the cleavage and connection of enzymes, and preventing the replication of bacterial DNA, and showing antibacterial activity. With broad-spectrum antibacterial activity, strong permeability, this product has a strong role in the killing of gram negative bacteria, but also have good antibacterial effects on Gram positive bacteria, good oral absorption, high blood concentration and stability, can be widely distributed in tissues, its metabolites for ciprofloxacin, there is still strong antibacterial effect. Almost all aquatic animals have strong antibacterial activity. Effective against severe infections caused by drug-resistant pathogens and cross resistance with other antibiotics.